EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Modified Atkins Diet for Treatment of Glucose Transporter Type 1 Deficiency Syndrome:

Eduarda Couto Plácido Nunes, Sandra Costa Valle

Saúde e Desenvolvimento Humano · 06.04.2026 · 13 (3) · e11968

DOI: 10.18316/sdh.v13i3.11968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saúde e Desenvolvimento Humano, online erschienen am 06.04.2026. Verfasst von Eduarda Couto Plácido Nunes und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Modified Atkins Diet (MAD) is a therapeutic strategy used in the management of Glucose Transporter Type 1 Deficiency Syndrome (GLUT1DS), a condition characterized by reduced glucose transport to the central nervous system. The induction of ketosis contributes to the control of neurological manifestations, particularly epileptic seizures.

Objective

To describe the implementation of the Modified Atkins Diet in a patient with GLUT1DS. Case report: A female patient with refractory epilepsy since 11 months of age and a diagnosis of GLUT1DS at 3 years of age. The MAD was initiated at 3 years and 9 months with a composition of 60–70% lipids, 24% protein, carbohydrate restriction to 15 g/day, and supplementation with a ketogenic formula (60 g/day). After six months, carbohydrate intake was adjusted to 25 g/day.

Results

A 60% reduction in seizure frequency was observed, with ketone body levels within the therapeutic target range and a reduction in antiepileptic medications. The patient and her family showed good adaptation to the dietary intervention. However, ketonemia monitoring was limited during the initial phases of the intervention due to the unavailability of testing supplies within the public health system, which restricted the assessment of ketosis intensity during this period.

Conclusion

The Modified Atkins Diet proved to be feasible and was associated with clinical improvement, reinforcing its therapeutic potential in the management of GLUT1DS.

Zitieren

APA

Nunes, E. C. P., & Valle, S. C. (2026). Modified Atkins Diet for Treatment of Glucose Transporter Type 1 Deficiency Syndrome:. Saúde e Desenvolvimento Humano, 13(3), e11968. https://doi.org/10.18316/sdh.v13i3.11968

Vancouver

Nunes ECP, Valle SC. Modified Atkins Diet for Treatment of Glucose Transporter Type 1 Deficiency Syndrome:. Saúde e Desenvolvimento Humano. 2026;13(3):e11968. doi:10.18316/sdh.v13i3.11968

BibTeX
@article{Nunes2026,
  author = {Nunes, Eduarda Couto Plácido and Valle, Sandra Costa},
  title = {Modified Atkins Diet for Treatment of Glucose Transporter Type 1 Deficiency Syndrome:},
  journal = {Saúde e Desenvolvimento Humano},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {e11968},
  doi = {10.18316/sdh.v13i3.11968}
}
Kostenlos starten →